Intracranial bleeding is a medical emergency that can result in the death of brain cells due to increased intracranial pressure, and patients with a brain hemorrhage may suffer coma or death without proper treatment. Although some individuals suffer brain hemorrhages due to brain tumors, head trauma or high blood pressure, use of the popular blood thinner medication Xarelto has also been linked to an increased risk of uncontrollable intracranial bleeding in patients. If you took Xarelto in the past, and you have since suffered intracranial bleeding or a severe cerebral hemorrhage, contact a knowledgeable product liability lawyer for legal help. You may be entitled to financial compensation for your injuries, which you can pursue by filing a lawsuit against the maker of the pharmaceutical drug.
Intracranial bleeding, also known as a brain hemorrhage or cerebral hemorrhage, is a type of stroke that occurs when a ruptured blood vessel causes bleeding in or around the brain. When bleeding occurs inside the brain, it can cause swelling that can increase pressure on the tissue surrounding the brain, reduce blood flow to this tissue and subsequently kill brain cells.
Depending on the circumstances surrounding a cerebral hemorrhage, bleeding can occur inside the brain, between the brain and the membranes that cover it, between the skull and the covering of the brain, or between the layers of the brain’s covering. The symptoms associated with bleeding on the brain depends on the severity of the bleeding and the location of the bleeding, and may include the following:
Cerebral hemorrhages account for approximately 13% of strokes, and can be caused by any number of factors, including head trauma, blood vessel abnormalities, high blood pressure, aneurysm, liver disease, brain tumors, blood or bleeding disorders, or a condition called amyloid angiopathy. In some cases, patients at risk for blood clots and stroke who take certain anticoagulant medications, like Xarelto, may face an increased risk of brain hemorrhages or intracranial bleeding that cannot be effectively controlled by doctors. According to the U.S. Food and Drug Administration (FDA)’s adverse event reporting system, Xarelto was identified as the suspected cause of serious bleeding side effects in 2,081 reports in 2012 alone, including at least 151 deaths.
The prognosis for patients with intracranial bleeding depends on the size of the brain hemorrhage and the amount of swelling, and some patients with bleeding on the brain may recover completely. However, some individuals with a cerebral hemorrhage may suffer devastating complications from the condition, including stroke, loss of brain function, and possibly even death. For patients taking Xarelto, the risk of severe intracranial bleeding is exceptionally high, due to the fact that the anticoagulant drug does not have an approved antidote. This means that doctors are unable to reverse the blood-thinning effects of the medication in the event of a brain hemorrhage or another serious bleeding event, increasing the risk of death or permanent injury.
Serious concerns have been raised recently about the safety of Xarelto, and the Institute for Safe Medication Practices (ISMP) has reported that the rate of uncontrollable bleeding and other side effects allegedly linked to Xarelto treatment is “steadily increasing,” as more and more patients are prescribed the anticoagulant drug. If you believe you have been adversely affected by alleged Xarelto inctracranial bleeding complications, consult an experienced brain hemorrhage attorney to discuss your options for legal recourse. With a qualified product liability lawyer on your side, you can protect your legal rights and seek fair and timely reimbursement for your injuries, medical expenses, and pain and suffering.